Cite
[Pharmacoeconomic evaluation of use of ciprofloxacin and norfloxacin with cost-benefit analysis].
MLA
Skrbo, Armin, et al. “[Pharmacoeconomic Evaluation of Use of Ciprofloxacin and Norfloxacin with Cost-Benefit Analysis].” Medicinski Arhiv, vol. 57, no. 5–6, 2003, pp. 285–89. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15022580&authtype=sso&custid=ns315887.
APA
Skrbo, A., Selava, A., & Zunić, L. (2003). [Pharmacoeconomic evaluation of use of ciprofloxacin and norfloxacin with cost-benefit analysis]. Medicinski Arhiv, 57(5–6), 285–289.
Chicago
Skrbo, Armin, Aida Selava, and Lejla Zunić. 2003. “[Pharmacoeconomic Evaluation of Use of Ciprofloxacin and Norfloxacin with Cost-Benefit Analysis].” Medicinski Arhiv 57 (5–6): 285–89. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15022580&authtype=sso&custid=ns315887.